Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin effect on platelet antiplasmins release.

A I Woods, M A Lazzari

    Thrombosis Research
    |August 1, 1987
    PubMed
    Summary

    Platelets significantly reduce fibrinolysis, with more platelets leading to less lysis. Collagen activation further enhances this antiplasmin effect, independent of aspirin. Platelet antiplasmins may use non-cyclooxygenase pathways.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical profile of the association of P.R1205h and P.R924q in a patient with von Willebrand's disease.

    Haemophilia : the official journal of the World Federation of Hemophilia·2013
    Same author

    Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis.

    Hematology (Amsterdam, Netherlands)·2012
    Same author

    C1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significance.

    Haemophilia : the official journal of the World Federation of Hemophilia·2011
    Same author

    von Willebrand's disease diagnosis and laboratory issues.

    Haemophilia : the official journal of the World Federation of Hemophilia·2010
    Same author

    Differential formation of a bioactive antiaggregating substance (BAS) by layers of the vein wall.

    Platelets·2010
    Same author

    Persistence of low platelet adhesiveness in von Willebrand disease during pregnancy.

    Platelets·2010

    Area of Science:

    • Hemostasis and Thrombosis
    • Fibrinolysis Research
    • Platelet Physiology

    Background:

    • Euglobulins are key components of the fibrinolytic system.
    • Platelets play a crucial role in hemostasis and can influence fibrinolysis.
    • Understanding platelet-fibrinolysis interactions is vital for managing bleeding and clotting disorders.

    Purpose of the Study:

    • To investigate the impact of platelets on euglobulin-mediated fibrinolysis.
    • To determine if platelet activation affects their antiplasmin activity.
    • To explore the role of aspirin and potential release pathways of platelet antiplasmins.

    Main Methods:

    • Assessing lysis areas on fibrin plates using euglobulins from platelet-poor plasma with and without added washed platelets.
    • Comparing lysis areas with non-activated versus collagen-activated platelets (2 and 20 µg/ml).
    • Evaluating the effect of aspirin on platelet antiplasmin activity in both non-activated and activated platelets.

    Main Results:

    • Platelets significantly decreased lysis areas, with the effect correlating to platelet number.
    • Collagen-activated platelets showed significantly lower lysis areas compared to non-activated platelets (p < 0.001).
    • Aspirin did not alter antiplasmin activity in either non-activated or activated platelets.

    Conclusions:

    • Platelets possess significant antiplasmin activity that modulates euglobulin-mediated fibrinolysis.
    • Platelet activation, particularly with collagen, enhances antiplasmin effects.
    • Platelet antiplasmins might be released via pathways independent of the cyclooxygenase pathway or are not stored in alpha-granules.

    Related Experiment Videos